查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1522996

呼吸障礙治療藥物市場報告：2030 年趨勢、預測與競爭分析

Breathing Disorder & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

治療呼吸疾病藥物的趨勢和預測

預計 2024 年至 2030 年，全球呼吸系統疾病治療藥物市場將以 15.6% 的複合年成長率成長。該市場的主要驅動力是人口中氣喘盛行率的增加以及導致呼吸問題的過敏反應發生率的增加。全球呼吸系統疾病藥物市場的未來充滿希望，醫院、診所、零售藥局和線上藥局市場都有機遇。

呼吸障礙治療藥物按細分市場

其中包括按類型、適應症、最終用途和地區分類的全球呼吸系統疾病治療市場的預測。

呼吸障礙治療藥物市場洞察

Lucintel 預測，由於呼吸道感染疾病和疾病的增加，抗生素將在預測期內經歷最高的成長。

在這個市場中，醫院將繼續成為最大的細分市場，因為它們的目標是提供專門的護理和藥物。

由於老年人口的成長和呼吸道疾病發病率的上升，預計北美在預測期內將經歷最高的成長。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球呼吸系統疾病治療藥物市場預計將以15.6%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要促進因素是人群中氣喘盛行率的增加以及導致呼吸問題的過敏反應發生率的增加。

Q3.市場的主要細分市場是：

A3. 呼吸系統疾病藥物市場前景廣闊，醫院、診所、零售藥局和網路藥局市場都有機會。

Q4.市場的主要企業是：

A4.主要企業如下：

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測，由於呼吸道感染疾病和疾病的增加，抗生素將在預測期內出現最高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於人口老化加劇和呼吸道疾病發生率增加，預計北美地區在預測期內將出現最高成長。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球呼吸系統疾病治療藥物市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球呼吸系統疾病治療藥物市場趨勢（2018-2023）與預測（2024-2030）
  • 全球呼吸系統疾病藥物市場（按類型）
    • 抗生素
    • 非類固醇消炎劑(NSAID)
    • 止咳藥
    • 鼻減充血劑
    • 其他
  • 全球呼吸系統疾病藥物市場（按適應症）
    • 慢性阻塞性肺病（COPD）
    • 氣喘
    • 過敏性鼻炎
    • 肺動脈高壓
    • 囊腫纖維化（CF）
    • 特發性肺纖維化
    • 其他
  • 全球呼吸系統疾病治療藥物市場（依最終用途）
    • 醫院和診所
    • 零售藥房
    • 網路藥房

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球呼吸系統疾病治療藥物市場（按地區）
  • 北美呼吸系統疾病治療藥物市場
  • 歐洲呼吸系統疾病治療藥物市場
  • 亞太地區呼吸系統疾病藥物市場
  • 其他區域呼吸系統疾病治療藥物市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球呼吸系統疾病藥物市場按類型分類的成長機會
    • 全球呼吸系統疾病治療市場成長機會（按適應症）
    • 全球呼吸系統疾病治療藥物市場成長機會（依最終用途）
    • 全球呼吸系統疾病治療藥物市場成長機會（按地區）
  • 全球呼吸系統疾病治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球呼吸系統疾病治療市場的產能
    • 全球呼吸系統疾病治療市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis
簡介目錄

Breathing Disorder & Treatment Trends and Forecast

The future of the global breathing disorder & treatment market looks promising with opportunities in the hospital, clinic, retail pharmacy, and online pharmacy markets. The global breathing disorder & treatment market is expected to grow with a CAGR of 15.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of asthma among the population and rising allergic reaction that causes breathing problem.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Breathing Disorder & Treatment by Segment

The study includes a forecast for the global breathing disorder & treatment by type, indication, end use, and region.

Breathing Disorder & Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antibiotics
  • Non-Steroidal Anti-Inflammatory Drug (NSAIDs)
  • Cough Suppressant
  • Nasal Decongestant
  • Others

Breathing Disorder & Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Allergic Rhinitis
  • Pulmonary Hypertension
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis
  • Others

Breathing Disorder & Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital and Clinics
  • Retail Pharmacies
  • Online Pharmacies

Breathing Disorder & Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breathing Disorder & Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breathing disorder & treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breathing disorder & treatment companies profiled in this report include-

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Breathing Disorder & Treatment Market Insights

Lucintel forecasts that antibiotic is expected to witness the highest growth over the forecast period due to rising respiratory infections and disorders.

Within this market, hospital will remain the largest segment as it aims at providing specialized care and medications.

North America is expected to witness the highest growth over the forecast period due to increasing geriatric population and rising cases of respiratory disorders in the region.

Features of the Global Breathing Disorder & Treatment Market

Market Size Estimates: Breathing disorder & treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breathing disorder & treatment market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Breathing disorder & treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indication, end uses, and regions for the breathing disorder & treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breathing disorder & treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for breathing disorder & treatment market?

Answer: The global breathing disorder & treatment market is expected to grow with a CAGR of 15.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the breathing disorder & treatment market?

Answer: The major drivers for this market are increasing prevalence of asthma among the population and rising allergic reaction that causes breathing problem.

Q3. What are the major segments for breathing disorder & treatment market?

Answer: The future of the breathing disorder & treatment market looks promising with opportunities in the hospital, clinic, retail pharmacy, and online pharmacy markets.

Q4. Who are the key breathing disorder & treatment market companies?

Answer: Some of the key breathing disorder & treatment companies are as follows:

  • AstraZeneca
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • Abbott
  • Medtronic
  • Hoffmann-La Roche
  • Novartis

Q5. Which breathing disorder & treatment market segment will be the largest in future?

Answer: Lucintel forecasts that antibiotic is expected to witness the highest growth over the forecast period due to rising respiratory infections and disorders.

Q6. In breathing disorder & treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period due to increasing geriatric population and rising cases of respiratory disorders in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breathing disorder & treatment market by type (antibiotics, non-steroidal anti-inflammatory drug (NSAIDs), cough suppressant, nasal decongestant, and others), indication (chronic obstructive pulmonary disease (COPD), asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis (CF), idiopathic pulmonary fibrosis, and others), end use (hospital and clinics, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breathing Disorder & Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breathing Disorder & Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breathing Disorder & Treatment Market by Type
    • 3.3.1: Antibiotics
    • 3.3.2: Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
    • 3.3.3: Cough Suppressant
    • 3.3.4: Nasal Decongestant
    • 3.3.5: Others
  • 3.4: Global Breathing Disorder & Treatment Market by Indication
    • 3.4.1: Chronic Obstructive Pulmonary Disease (COPD)
    • 3.4.2: Asthma
    • 3.4.3: Allergic Rhinitis
    • 3.4.4: Pulmonary Hypertension
    • 3.4.5: Cystic Fibrosis (CF)
    • 3.4.6: Idiopathic Pulmonary Fibrosis
    • 3.4.7: Others
  • 3.5: Global Breathing Disorder & Treatment Market by End Use
    • 3.5.1: Hospital and Clinics
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breathing Disorder & Treatment Market by Region
  • 4.2: North American Breathing Disorder & Treatment Market
    • 4.2.1: North American Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.2.2: North American Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.3: European Breathing Disorder & Treatment Market
    • 4.3.1: European Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.3.2: European Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.4: APAC Breathing Disorder & Treatment Market
    • 4.4.1: APAC Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.4.2 APAC Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies
  • 4.5: ROW Breathing Disorder & Treatment Market
    • 4.5.1: ROW Breathing Disorder & Treatment Market by Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and Others
    • 4.5.2: ROW Breathing Disorder & Treatment Market by End Use: Hospital and Clinics, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Indication
    • 6.1.3: Growth Opportunities for the Global Breathing Disorder & Treatment Market by End Use
    • 6.1.4: Growth Opportunities for the Global Breathing Disorder & Treatment Market by Region
  • 6.2: Emerging Trends in the Global Breathing Disorder & Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breathing Disorder & Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breathing Disorder & Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AstraZeneca
  • 7.2: GlaxoSmithKline
  • 7.3: Merck Sharp & Dohme
  • 7.4: Abbott
  • 7.5: Medtronic
  • 7.6: Hoffmann-La Roche
  • 7.7: Novartis